These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 8774108)
1. Tamoxifen and the uterus: an old drug tested by new modalities. Achiron R; Grisaru D; Golan-Porat N; Lipitz S Ultrasound Obstet Gynecol; 1996 May; 7(5):374-8. PubMed ID: 8774108 [TBL] [Abstract][Full Text] [Related]
2. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study. Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913 [TBL] [Abstract][Full Text] [Related]
3. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow. Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941 [TBL] [Abstract][Full Text] [Related]
4. Tamoxifen induced endometrial abnormalities: evaluation by saline infusion sonohysterography. Jaeger BM; Grumbach K Md Med J; 1997 Sep; 46(8):433-5. PubMed ID: 9294952 [TBL] [Abstract][Full Text] [Related]
5. Aromatase inhibitors and postmenopausal breast cancer patients with tamoxifen-induced endometrial pathology. Morales L; Paridaens R; Timmerman D; Neven P Clin Cancer Res; 2006 Sep; 12(18):5603. PubMed ID: 17000698 [No Abstract] [Full Text] [Related]
6. Endometrial evaluation with transvaginal US and hysterosonography in asymptomatic postmenopausal women with breast cancer receiving tamoxifen. Fong K; Kung R; Lytwyn A; Trudeau M; Chapman W; Nugent P; Glanc P; Manchul L; Szabunio D; Myhr T Radiology; 2001 Sep; 220(3):765-73. PubMed ID: 11526280 [TBL] [Abstract][Full Text] [Related]
7. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy. McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294 [TBL] [Abstract][Full Text] [Related]
8. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study. Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921 [TBL] [Abstract][Full Text] [Related]
9. [Comparative study of the endometrial pathology using flexible ambulatory hysteroscopy of patients treated with Tamoxifen]. Kuzmanov B Akush Ginekol (Sofiia); 2004; 43(3):32-3. PubMed ID: 15341254 [TBL] [Abstract][Full Text] [Related]
10. The value of transvaginal ultrasonography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients. Markovitch O; Tepper R; Fishman A; Shapira J; Aviram R; Cohen I Gynecol Oncol; 2004 Dec; 95(3):456-62. PubMed ID: 15581946 [TBL] [Abstract][Full Text] [Related]
11. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium. Achiron R; Lipitz S; Sivan E; Goldenberg M; Mashiach S J Ultrasound Med; 1995 Sep; 14(9):685-8. PubMed ID: 7500435 [TBL] [Abstract][Full Text] [Related]
12. Significance of endovaginal ultrasonography in assessing tamoxifen-associated changes of the endometrium. A prospective study. Strauss HG; Wolters M; Methfessel G; Buchmann J; Koelbl H Acta Obstet Gynecol Scand; 2000 Aug; 79(8):697-701. PubMed ID: 10949237 [TBL] [Abstract][Full Text] [Related]
13. Endometrial thickness of postmenopausal breast cancer patients treated with tamoxifen. Salazar EL; Paredes A; Calzada L Gynecol Endocrinol; 2005 Dec; 21(6):312-6. PubMed ID: 16390778 [TBL] [Abstract][Full Text] [Related]
14. [The progesterone test and transvaginal sonography as methods for the early discovery and screening of endometrial cancer in women in the postmenopause from some risk groups]. Ivanov S; Ivanov S Akush Ginekol (Sofiia); 1999; 38(2):29-30. PubMed ID: 10730382 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of endometrium by transvaginal ultrasonography and Doppler in tamoxifen-treated women with breast cancer. Bezircioglu I; Baloglu A; Tarhan MO; Oziz E; Yigit S Eur J Gynaecol Oncol; 2012; 33(3):295-9. PubMed ID: 22873103 [TBL] [Abstract][Full Text] [Related]
16. Mitotically active leiomyoma of the uterus in a postmenopausal breast cancer patient receiving tamoxifen. Liu IF; Yen YS; Cheng YM; Chou CY Taiwan J Obstet Gynecol; 2006 Jun; 45(2):167-9. PubMed ID: 17197361 [TBL] [Abstract][Full Text] [Related]
17. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800 [TBL] [Abstract][Full Text] [Related]
19. Errors in the measurement of endometrial depth using transvaginal sonography in postmenopausal women on tamoxifen: random error is reduced using saline instillation sonography. Ballard P; Tetlow R; Richmond I; Killick S; Purdie DW Ultrasound Obstet Gynecol; 2000 Apr; 15(4):321-6. PubMed ID: 10895453 [TBL] [Abstract][Full Text] [Related]
20. Transvaginal ultrasonography and endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Dijkhuizen FP; Brölmann HA; Oddens BJ; Roumen RM; Coebergh JW; Heintz AP Maturitas; 1996 Aug; 25(1):45-50. PubMed ID: 8887308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]